Role of tachykinins in castor oil diarrhoea in rats

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 375-380

  Croci, Tiziano ^a   Landi, Marco ^a   Emonds Alt, Xavier ^b   Le Fur, Gérard ^b   Maffrand, Jean Pierre ^b   Manara, Luciano ^a  

^a Research Center Sanofi Midy   (Italy)

^b SANOFI   (France)

Author keywords

Castor oil diarrhoea; Gut motility; Loperamide; Naloxone; NK1 receptor; NK2 receptor; SR 140333; SR 48968; Tachykinins

Indexed keywords

CASTOR OIL; FOROPAFANT; LOPERAMIDE; NALOXONE; NEUROKININ A; NOLPITANTIUM; SAREDUTANT; SR 48605; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DESCENDING COLON; DIARRHEA; DOSE RESPONSE; GASTROINTESTINAL TRANSIT; INTESTINE CONTRACTION; INTESTINE MOTILITY; MALE; MANOMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSVERSE COLON; WATER CONTENT;

ANIMALS; BENZAMIDES; CASTOR OIL; COLON; DIARRHEA; GASTROINTESTINAL MOTILITY; LOPERAMIDE; MALE; NALOXONE; PIPERIDINES; QUINUCLIDINES; RATS; TACHYKININS;

EID: 0030920003     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701130     Document Type: Article

References (28)

1. 2) receptor revisited with SR 48968 a potent non-peptide antagonist. Biochem. Biophys. Res. Commun., 184, 1418-1424.
2. ANDERSEN, M.B., STIDKILDE-JØRGENSEN, H. & GREGERSEN, H. (1991). Versatile software system for analysis of gastrointestinal pressure recordings. Dig. Dis., 9, 382-388.
3. BARONE, F.C., DEEGAN, J.F., PRICE, W.J., FOWLER, P.J., FONDACARO, J.D. & ORMSBEE III, H.S. (1990). Cold-restraint stress increases rat fecal pellet output and colonic transit. Am. J. Physiol., 258, G329-G337.
4. 3-tachykinin and μ-opioid receptors. Br. J. Pharmacol., 108, 24P.
5. G-nitro-L-arginine methyl ester. Br. J. Pharmacol., 113, 1127-1130.
6. 1A agonist 8-OH-DPAT. Dig. Dis. Sci., 39, 1968-1973.
7. 2-antagonist, SR 48968, prevents castor oil induced diarrhoea in rats. Neurogastroenterol. Motil., 8, 166.
8. 2 receptor antagonists, SR 140333 and SR 48968 in different rat and guinea-pig intestinal segments. Life Sci., 56, 267-275.
9. 2 receptors in rats. J. Pharm. Pharmacol., 46, 383-385.
10. 8]NKA-induced rat colonic contractions. Br. J. Pharmacol., 111, 254P.
11. DESHPANDE, Y., LONGO, W.E., CHANDEL, B., NIEHOFF, M., ROBINSON, S., POLITIES, G., VERNAVA, A.M. & KAMINSKI, D.L. (1994). Effect of platelet-activating factor and its antagonists on colonic dysmotility and tissue levels of colonic neuropeptides. Eur. J. Pharmacol., 256, R1-R3.
12. DI SEBASTIANO, P., GROSSI, L., ANGELUCCI, D., DI MOLA, F., TRAVAGLINI, N., DIODORO, M.G., FRIESS, H., BUECHLER, M.W., MAEZIO, L. & INNOCENTI, P. (1996). Morphological and motor changes during experimental colitis in rats are prevented by a specific substance P antagonist. Gastroenterology, 110, A896.
13. 2 receptors in rat colonic hypersecretion induced by Interleukin 1β: role of nitric oxide. Gastroenterology, 109, 483-489.
14. GIUDICE, A., HERBERT, J.M., MAFFRAND, J.P., MANARA, L., MANZONI, L. & LE FUR, G. (1996). Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethyl-aminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphenyl) thiazol-2yl]a-mine. Arzneim.-Forsch. Drug Res., 46, 407-412.
15. 2 receptor subtype. Eur. J. Pharmacol., 203, 365-370.
16. 2 neurokinin receptors and their utilisation to localize receptors in the rat gastrointestinal tract. J. Neurosci., 16, 6975-6986.
17. HOLZER-PETSCHE, U. (1995). Tachykinin receptors in gastrointestinal motility. Regul. Peptides, 57, 19-42.
18. 1 receptor antagonist, decreased restraint stress-induced defecation in rat. Neurosci. Lett., 198, 103-106.
19. KRAMER, C.Y. (1956). Extension of multiple range test to groups with unequal numbers of replications. Biometrics, 12, 307-310.
20. 2 receptor antagonist. Eur. J. Pharmacol., 234, 83-90.
21. MARTIN, C.A.E., EMONDS-ALT, X. & ADVENIER, C. (1993). Inhibition of cholinergic neurotransmission in isolated guinea-pig main bronchi by SR 48968. Eur. J. Pharmacol., 243, 309-312.
22. MASCOLO. N., IZZO, A.A., ALITORE, G., BARBATO, F. & CAPASSO, F. (1994). Nitric oxide and castor oil-induced diarrhea. J. Pharmacol. Exp. Ther., 268, 291-295.
23. MEINI, S. & MAGGI, C.A. (1994). Evidence for a capsaicin-sensitive, tachykinin-mediated, component in the NANC contraction of the rat urinary bladder to nerve stimulation. Br. J. Pharmacol., 112, 1123-1131.
24. PINTO, A., AUTORE, G., MASCOLO, N., SORRENTINO, R., BIONDI, A., IZZO, A.A & CAPASSO, F. (1992). Time course of PAF formation by gastrointestinal tissue in rats after castor oil challenge. J. Pharm. Pharmacol., 44, 224-226.
25. PINTO, A., CALIGNANO, A., MASCOLO, N., AUTORE, G. & CAPASSO, F. (1989). Castor oil increases intestinal formation of platelet-activating factor and acid phosphatase release in the rat. Br. J. Pharmacol., 96, 872-874.
26. PONS, L., DROY-LEFAIX, M.T. & BUENO, L. (1994). Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats. Prostaglandins, 47, 123-136.
27. POTHOULAKIS, C., CASTAGLIUOLO, I., LAMONT, J.T., JAFFER, A., O'KEANE, J.C., SNIDER, R.M. & LEEMAN, S.E. (1994). CP-96.345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc. Natl. Acad. Sci. U.S.A., 91, 947-951.
28. STERNINI, C., SU, D., GAMP, P.D. & BUNNETT, N.W. (1995). Cellular sites of expression of the neurokinin-1 receptor in the rat gastrointestinal tract. J. Comp. Neurol., 358, 531-540.